FilingIndex
6-KThe Wire

Evogene Ltd. files 6-K

Filed Mar 5, 2026 · 4mo ago · Accession 0001178913-26-000743

Plain English

Evogene Ltd. reported its financial results for the fourth quarter and full year ended December 31, 2025. The company is holding a conference call on March 5, 2026, to discuss these results and will provide a slide presentation with additional information.

Read the original on SEC.gov ↗
Filing details
Ticker
EVGN
CIK
1574565
Form type
6-K
Filing date
Mar 5, 2026
Report date
Mar 5, 2026
Document
zk2634488.htm
Size
4.1 MB